HealthEquity Surpasses Industry Growth with 19% HSA Asset Expansion in Q1 2027
HealthEquity, a leading healthcare financial platform company, has announced impressive first quarter fiscal 2027 earnings, exceeding industry growth expectations and reinforcing confidence in its long-term growth outlook.
In a conference call on May 28th, 2026, Scott Cutler, President and CEO of HealthEquity, highlighted the company's disciplined execution against its mission and the strength of its financial model. The results demonstrate the company's ability to empower healthcare consumers while driving operational leverage and durable growth across the business.
Healthcare affordability remains a significant financial challenge for families, with rising healthcare costs driving a structural shift among employers that continues to expand the overall market. Against this backdrop, HealthEquity's first quarter results reflect its capacity to adapt to these changes and position itself as a leader in the industry.
The company reported 19% growth in total HSA assets, outperforming Devenir's reported market growth of 6% for calendar year 2025. This impressive expansion demonstrates HealthEquity's ability to bend the growth curve and achieve consistent results despite industry-wide challenges.
Importantly, new HSAs from sales grew 15%, introducing 172,000 new HSAs to HealthEquity's platform. Client retention remains strong, with opportunities to win new clients and expand existing relationships. The company's data and analytics capabilities are an essential differentiator as clients seek ways to improve adoption, increase contributions, and manage healthcare costs over the long term.
In addition to account growth, engagement is a key driver of HealthEquity's business. Members are engaging more deeply as they save, spend, and invest. This increased participation reflects the company's strategy to make its platform the healthcare financial operating system for members and clients, expanding the value of each relationship while improving efficiency as it scales.
The company has also demonstrated its commitment to disciplined capital allocation by raising its fiscal 2027 guidance and increasing its share repurchase authorization by $1 billion. This strategic move reinforces confidence in HealthEquity's long-term growth outlook and reflects the company's ability to adapt to changing market conditions while maintaining a strong financial position.
Overall, HealthEquity's impressive first quarter results demonstrate its capacity to drive durable growth across the business, expand the lifetime value of each member relationship, and position itself as a leader in the industry. With its scaled healthcare financial platform and commitment to disciplined capital allocation, HealthEquity is well-positioned for continued success and growth in the years ahead."
